Cipla Reports 55% Drop in Q4 Net Profit, 26% Decline in FY26 PAT
Cipla announced a 55% drop in Q4 net profit to ₹555 crore and a 3% decrease in total income to ₹6,541 crore. For FY26, revenue grew 2% to ₹28,163 crore, but PAT declined 26% to ₹3,879 crore. MD Achin Gupta highlighted strong performance in key therapy areas and sustained growth in generics and consumer health. The board recommended a final dividend of ₹13 per equity share.
The company's performance was mixed, with challenges in profitability but strengths in specific business segments.